None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 50 to 70 years old, gender not limited; 2.No contraindications for colonoscopy examination, planned to undergo colonoscopy examination in the near future; 3.Agree to participate in this study;
Exclusion criteria
Exclusion criteria: 1. Patients with a history of colorectal surgery (resection of malignant tumors, resection of colorectal perforation, etc.); 2. Electrolyte imbalance, hemodialysis patients; 3. Patients with active lower gastrointestinal bleeding; 4. Patients with coagulation dysfunction; 5. Patients with severe primary diseases of the lungs, liver, kidneys, hematopoietic system, etc., and liver function ALT and AST exceeding 1.5 times the upper limit of the reference value, or Cr exceeding the upper limit of the reference value; 6. Merge other diseases that may affect the efficacy judgment or pose significant risks, such as acute phase of inflammatory bowel disease, colon cancer, intussusception, intestinal torsion, intestinal obstruction, peritonitis, ascites, refractory constipation, etc; 7. Patients with mental illness and severe neurological disorders; 8. Known patients with allergies to the test drug or control drug; 9. Participated in other clinical researchers within one month; 10. Researchers believe that there are other situations that are not suitable for inclusion, and patients are unwilling to join the group;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bowel preparation qualification rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adenoma detection rate;Adverse Effects Rate; | — |
Countries
China
Contacts
Nanjing Drum Tower Hospital The Affiliated Hosipital of Nanjing University Medical School